All Online

13 - 15 of 15 results

Refine

Active filters

Geriatrics
Elderly man with physician
0.29 CME CREDIT

Alzheimer disease (AD) is a growing concern as the population ages. Primary care clinicians are often the first to screen for and identify signs of cognitive impairment which may be due to AD. Join neurologist Gad Marshall, MD in this two-part podcast series, as he answers important questions and provides helpful tips for assessing cognitive impairment in primary care and provides insight into the current and emerging role of neuroimaging and biomarkers in the diagnosis of AD. The topics covered in this podcast are based on challenges and misconceptions identified from the CME/CE curriculum The Future of Alzheimer Disease: Early Recognition and Emerging Therapy.


Elderly patient holding doctors hands
0.25 CME CREDIT

Alzheimer disease (AD) treatment is evolving. With this rapid expansion in potential therapies, there remain challenges and misconceptions. Join neurologist Gad Marshall, MD in this two-part podcast series, as he answers important questions about new and emerging disease-modifying therapies and explores ways in which these treatments may be considered in the future for patients. The topics covered in this podcast are based on challenges and misconceptions identified from the CME/CE curriculum The Future of Alzheimer Disease: Early Recognition and Emerging Therapy.


Tile overview image
1 CME CREDIT

Managing Patients with Cognitive Decline in Primary Care

1.00 CME/MOC
1.00 AANP | 0.25 Pharmacology

Faculty will outline the clinical findings, screening tools, diagnostic studies, and potential therapies for cognitive decline in the geriatric patient.